Microfinance Institutions as a Platform for Global Health
NCT ID: NCT02808117
Last Updated: 2016-11-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
526 participants
OBSERVATIONAL
2015-05-31
2016-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The investigators intend to analyze data from a pilot program implemented by an MFI in Haiti during 2011-2012 that distributed an evidence-based health good, micronutrient powders (MNPs), to 526 children in 34 villages where the MFI operates. Micronutrient deficiency is estimated to be responsible for over 1 million deaths of children under five per year. MNPs are one form of micronutrient supplementation proven to effectively combat micronutrient deficiency.
Published cost estimates indicate that leveraging existing supply chains could cut the total cost of mass MNP delivery by 25%. Given MFIs reach 200 million households globally, MFI-based delivery of health goods may be a promising route to improving health outcomes efficiently.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Targeted initially
Children who were in the Haiti villages and targeted by the MFI program with MNP delivery initially.
MNP
Program that delivered MNP and implemented by an MFI in Haiti during 2011-2012.
One form of micronutrient supplementation proven to effectively combat micronutrient deficiency.
Targeted later
Children who were in the Haiti villages and not targeted by the MFI program with MNP delivery until later.
MNP
Program that delivered MNP and implemented by an MFI in Haiti during 2011-2012.
One form of micronutrient supplementation proven to effectively combat micronutrient deficiency.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
MNP
Program that delivered MNP and implemented by an MFI in Haiti during 2011-2012.
One form of micronutrient supplementation proven to effectively combat micronutrient deficiency.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Severely malnourished (Mid Upper Arm Circumference \< 110 mm)
6 Months
54 Months
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Columbia University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Aaron Isaac Baum
Co-Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Aaron I Baum, PhD
Role: STUDY_DIRECTOR
Columbia University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Columbia University
New York, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AAAP7004
Identifier Type: -
Identifier Source: org_study_id